APBD Research Foundation retweeted
excited to share our clinical experience diagnosing a rare adult onset inherited disorder - hopefully this should increase awareness and decrease time to diagnosis @APBDRF
Happy to share this teaching case with the amazing @JennOligoMyelin. Can you guess the diagnosis? @JAMANeuro bit.ly/40nH0Qm
61yo man presenting with 4 years of progressive weakness, gait instability, urinary incontinence, and cognitive changes. (1/6)
APBD Research Foundation retweeted
Mark your calendars for #RareDiseaseDay on Feb. 27–28!
@ncats_nih_gov & @US_FDA are teaming up for a two-day, hybrid #RDDatFDANIH event! RSVP now to listen and engage with panel discussions, #RareDiseases stories, and more: go.nih.gov/CaSKChZ
#FDA #NIH
APBD Research Foundation retweeted
Where do pediatric patients & families learn about #GeneTherapy? 🧬📢 The majority - 77% - turn to patient advocacy organizations! Social media/online forums follow at 51%, while only 33% hear from healthcare providers. A clear call to bolster nonprofits like @APBDRF! @FDACBER
APBD Research Foundation retweeted
Grateful to @RareDiseases for an inspiring #NORDSummit this week! Connecting with passionate patient advocates & dial-movers was invaluable. Key takeaways: we must prioritize equity, transparency, and sharing of resources to strengthen our community 🧬🦓 #RareDisease #GeneChat
APBD Research Foundation retweeted
Q: How do you know what is important to patients?
"Go to the patient advocacy organizations. They are the heartbeat of the patient population." Natasha Pires @APBDRF @cziscience
APBD Research Foundation retweeted
Happening now: our final session for the day, Beyond #LaforaDisease: A Coalition of n-GSDs, chaired by Dr. Berge Minassian.
Thank you Dr. Deberah Goldman for sharing about your experiences with APBD and the need for a common treatment ground. @APBDRF
#LaforaSymposium24
APBD Research Foundation retweeted
🚀 Exciting research from @Hopkins_Rad brought to us by Nirbhay Yadav today! He highlighted how his team is focusing on an imaging method to capture the metabolic marker in the brain behind glycogen storage diseases #raredisease #glycogenstoragedisease #glycogen #medtwitter #mri
APBD Research Foundation retweeted
Dr. Marvin Natowicz from the @ClevelandClinic breaks down the key categories of biomarkers - diagnostic, monitoring, predictive, susceptibility, and safety biomarkers 🧪 But what are the major challenges in their development and clinical use? Let’s talk about it 🧵 #biomarkers
APBD Research Foundation retweeted
The power of HOPE from an APBD caretaker: Having a bold vision & letting it guide our efforts is the key to real progress. Our vision is a future where APBD becomes a completely manageable disease. "We all know this is a life-or-death mission." #raredisease #genechat
APBD Research Foundation retweeted
Huge thanks to Jill Morris with @NIH_NINDS for sharing an incredibly helpful, tangible tool with our audience today! 📢 Don't miss out—join the NIH ListServ to access webinars tailored to specific funding opportunities:
list.nih.gov/cgi-bin/wa.exe?… #raredisease #genechat #NIH #APBD
APBD Research Foundation retweeted
"... lengthy time from early development to treatments in patients, high failure rate of promising treatment candidates, limited resources including funding, lack of awareness, and more." #raredisease
APBD Research Foundation retweeted
"The challenges we face are similar to what many rare disease communities face: a small number of geographically dispersed patients, heterogeneity of symptoms, slowly progressing disease, insufficient data and data silos..." #raredisease
APBD Research Foundation retweeted
Kicking off Day 2 of the 2024 @APBDRF Conference with a powerful word cloud & inspiring opening remarks from our Executive Director, Natacha Pires. A standout submission: "My only lifeline" - a poignant reminder of the impact this work has on our community. #genechat #raredisease
APBD Research Foundation retweeted
Wrapping up the @APBDRF conference this afternoon with an exciting panel on the critical role of Genetic Screening & Molecular Testing, featuring experts from @MyJScreen and @GeneDx. As a genetic counselor, I may be biased—but I’ve been waiting for this one all day! #genechat
APBD Research Foundation retweeted
Fantastic discussion during today’s "Strategies for Advancing @APBDRF and Rare Disease Research" panel! Dr. Matthew Gentry, Dr. Priya Kishnani, & Dr. Rebecca Koch highlighted the power of collaboration between patient advocacy organizations to drive progress toward shared goals.
APBD Research Foundation retweeted
Yaniv Glazer of GHF highlights the challenge of balancing compassionate use with drug development. Although compassionate use offers valuable insights and access, data isn't applicable for regulatory approval, which can slow progress for broader clinical trials for the community.
APBD Research Foundation retweeted
An honor to hear from the remarkable @DrStanleyCrooke! @n_lorem's mission to treat nano-rare diseases has resulted in >130 patient-driven drug discovery programs, 20+ INDs by year-end, & 7 patients already seeing clinically significant benefits. Truly extraordinary progress!
APBD Research Foundation retweeted
Dr. Su Jin Choi from @DukeHealth emphasized the complexity of the APBD disease mechanism by exploring the potential of an AAV-mediated glycogen clearance approach. While promising, this method showed a limited window of therapeutic efficacy. #genetherapy #raredisease #APBD
APBD Research Foundation retweeted
Dr. Berge Minassian leaves us with a thought-provoking insight: While the urgency for our patients is undeniable, the relatively slow progression of APBD makes it challenging to conduct clinical trials effectively. #raredisease #genechat #medtwitter #APBD
APBD Research Foundation retweeted
At our "Emerging Therapies in Development for APBD" session, Dr. Matthew Gentry & Dr. Berge Minassian share an increasing focus on developing a single drug that targets polyglucosan to address multiple diseases, including APBD, Pompe, Cori, Lafora, & RBCK1 deficiency #raredisease












